Back
CASI Pharmaceuticals Stock Price Chart
Sponsored
CASI
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
CASI
CASI Pharmaceuticals
Last Price:
5.25
Seasonality Move:
7.64%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CASI is experiencing slight buying pressure.
CASI Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.52 | Sell |
20-day SMA: | 5.78 | Sell |
50-day SMA: | 5.93 | Sell |
200-day SMA: | 4.97 | Buy |
8-day EMA: | 5.5 | Sell |
20-day EMA: | 5.66 | Sell |
50-day EMA: | 5.83 | Sell |
200-day EMA: | 5.28 | Sell |
CASI Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 41.4 | Sell |
Chaikin Money Flow: | 19222 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.43 - 6.03) | Sell |
Bollinger Bands (100): | (5.66 - 6.74) | Sell |
CASI Pharmaceuticals Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for CASI Pharmaceuticals Stock
Is CASI Pharmaceuticals Stock a Buy?
- CASI Pharmaceuticals share price is 5.26 while CASI 8-day simple moving average is 5.52, which is a Sell signal.
- The stock price of CASI is 5.26 while CASI Pharmaceuticals 20-day SMA is 5.78, which makes it a Sell.
- CASI Pharmaceuticals 50-day simple moving average is 5.93 while CASI share price is 5.26, making it a Sell technically.
- CASI stock price is 5.26 and CASI Pharmaceuticals 200-day simple moving average is 4.97, creating a Buy signal.
CASI Technical Analysis vs Fundamental Analysis
Buy
52
CASI Pharmaceuticals (CASI)
is a Buy
Is CASI Pharmaceuticals a Buy or a Sell?
-
CASI Pharmaceuticals stock is rated a Buy
The current CASI Pharmaceuticals [CASI] share price is $5.26. The Score for CASI is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
CASI Pharmaceuticals Stock Info
Market Cap:
81.33M
Price in USD:
5.26
Share Volume:
62.68K
CASI Pharmaceuticals 52-Week Range
52-Week High:
8.48
52-Week Low:
2.05
Buy
52
CASI Pharmaceuticals (CASI)
is a Buy
CASI Pharmaceuticals Share Price Forecast
-
What is the CASI Pharmaceuticals stock price today?
The CASI Pharmaceuticals stock price is 5.26 USD today. -
Will CASI stock go up or go down?
CASI Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is CASI Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, CASI Pharmaceuticals is not overvalued.
Is CASI Pharmaceuticals Stock a Buy?
- CASI Pharmaceuticals share price is 5.26 while CASI 8-day exponential moving average is 5.50, which is a Sell signal.
- The stock price of CASI is 5.26 while CASI Pharmaceuticals 20-day EMA is 5.66, which makes it a Sell.
- CASI Pharmaceuticals 50-day exponential moving average is 5.83 while CASI share price is 5.26, making it a Sell technically.
- CASI stock price is 5.26 and CASI Pharmaceuticals 200-day simple moving average is 5.28, creating a Sell signal.
Fundamental Analysis of CASI Pharmaceuticals
Is CASI Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.93 per share, and an increase next year of $0.34 per share.
Technical Analysis of CASI Pharmaceuticals
Should I short CASI Pharmaceuticals stock?
- CASI Moving Average Covergence Divergence (MACD) indicator is -0.14, suggesting CASI Pharmaceuticals is a Sell
- CASI Pharmaceuticals Relative Strength Index (RSI) is 41.4, which suggest CASI Pharmaceuticals is oversold
- The Bollinger Bands (25) for CASI Pharmaceuticals is (5.43 - 6.03), which suggest CASI Pharmaceuticals is a Sell
- The Bollinger Bands (100) for CASI Pharmaceuticals is (5.66 - 6.74), which suggest CASI Pharmaceuticals is a Sell
* CASI Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.